P. Chiodera et al., DIFFERENT EFFECTS OF THE SEROTONERGIC AGONISTS BUSPIRONE AND SUMATRIPTAN ON THE POSTERIOR PITUITARY HORMONAL RESPONSES TO HYPOGLYCEMIA IN HUMANS, Neuropeptides, 30(2), 1996, pp. 187-192
The responses of serum oxytocin (OT) and vasopressin (AVP) to the sero
tonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumat
riptan (6 mg injected subcutaneously) were evaluated in 7 normal men e
ither in basal conditions or during an insulin (0.15 iu/kg as an i.v.
bolus) tolerance test (ITT). Neither buspirone nor sumatriptan adminis
tration modified the basal secretion of AVP and OT. Stimulation of 5HT
-1D receptors with sumatriptan was unable to change neither AVP nor OT
response to insulin-induced hypoglycemia. On the other hand, the pret
reatment with the 5HT1A agonist buspirone significantly enhanced the O
T response during hypoglycemia, without modifying the AVP rise. The re
sults of this study suggest that serotonergic 5HT1A receptors may inte
ract with hypoglycemia in the stimulation of OT, but not AVP secretion
.